Papilloma truncated L1 protein and fusion protein constructs

US6562351B2 · kind B2 · utility

Assignee

• Medi&Gene Inc. · DE

Inventors

• Michael Hallek · Cologne, DE
• Alexander Burger · Munich, DE

Key dates

• Filing date: Nov 7, 2001
• Grant date: May 13, 2003
• Expiry date: Nov 7, 2021

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S977/918
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.